In contrast to our findings, after accounting for patient age, hospital-based case–control studies of BC among HL survivors have not found a significant variation in hormone-receptor status when compared with primary BC controls (Gaffney et al, 2001; Janov et al, 2001; Castiglioni et al, 2007). This evidence concerns the gene NR4A1 and Hodgkins lymphoma.